| Model Number |
EVOLUTR-34-US |
| Medical Device Problem Codes |
Fluid/Blood Leak (1250); Insufficient Device Problem Information (3190); Intravalvular regurgitation (4068)
|
| Health Effect - Clinical Codes |
Valvular Insufficiency/ Regurgitation (4449); Aortic Valve Insufficiency/ Regurgitation (4450); Insufficient Information (4580)
|
| Date of Event |
10/21/2025
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
It was reported that approximately 7 years and 9 months following the implant of a transcatheter valve, the valve failed due to an unknown reason.No patient complications were reported as a result of this event.
|
| |
|
Additional Manufacturer Narrative
|
|
Updated data: b1.B2.B5.H1.H6.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
Additional information was received that the valve failed due to severe aortic regurgitation.Subsequently, a non-medtronic transcatheter valve was implanted valve-in-valve.
|
| |
|
Event or Problem Description
|
|
It was reported that approximately 7 years and 9 months following the implant of a transcatheter valve, the valve failed due to an unknown reason.No patient complications were reported as a result of this event.Additional information was received that the valve failed due to severe aortic regurgitation.Subsequently, a non-medtronic transcatheter valve was implanted valve-in-valve.Additional information was received indicating that the severe aortic regurgitation was central in origin.
|
| |
|
Additional Manufacturer Narrative
|
|
Additional information: b5 (third paragraph) and h6.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Search Alerts/Recalls
|